Clinical Trial Update: Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tislelizumab in combination with GP or TPC regimens for nasopharyngeal carcinoma with bone metastasis is currently recruiting. The sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: XIANG YANQUN | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING